Alembic Pharmaceuticals successfully completes USFDA inspection for API-III facility

Alembic Pharmaceuticals Limited has successfully completed the United States Food and Drug Administration (USFDA) inspection for its API-III Facility located at Karakhadi. This was a scheduled GMP inspection and was successfully completed without any Form 483 observation. The inspection was conducted from 17th March, 2025 to 21st March, 2025.

Shelter Pharma secures order from Berlin International

Shelter Pharma Limited secured a noteworthy order from Berlin International Co. For 6000 of Beta Glucan Forte Syrup 100ml, total order worth is $ 9900.